| (2,4,5-trichlorophenoxy)acetic acid | increases expression | EXP | | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
| (2,4,5-trichlorophenoxy)acetic acid | increases expression | ISO | RGD:10652 | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
| (R)-lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:16249512 PMID:17940886 |
| (R)-lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:17940886 PMID:16249512 |
| (S)-nicotine | multiple interactions | ISO | RGD:10652 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of GCLC mRNA; more ... | CTD | PMID:20230807 |
| 1,1'-azobis(N,N-dimethylformamide) | increases activity | ISO | RGD:619868 | 6480464 | Diamide results in increased activity of GCLC protein | CTD | PMID:15115889 |
| 1,1'-azobis(N,N-dimethylformamide) | increases expression | ISO | RGD:619868 | 6480464 | Diamide results in increased expression of GCLC mRNA; more ... | CTD | PMID:15115889 |
| 1,3-benzothiazole-2-thiol | increases expression | EXP | | 6480464 | captax results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| 1-chloro-2,4-dinitrobenzene | increases expression | EXP | | 6480464 | Dinitrochlorobenzene results in increased expression of GCLC mRNA | CTD | PMID:20146380 PMID:20566472 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:10652 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GCLC mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:10652 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of GCLC mRNA; more ... | CTD | PMID:20230807 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:619868 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of GCLC mRNA | CTD | PMID:20551477 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of GCLC mRNA | CTD | PMID:20170705 |
| 1H-pyrazole | increases expression | ISO | RGD:10652 | 6480464 | pyrazole results in increased expression of GCLC mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:19542225 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:619868 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCLC mRNA | CTD | PMID:21215274 PMID:23238561 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15328365 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCLC mRNA | CTD | PMID:20702594 PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:19542225 PMID:21802500 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [NFE2L2 gene mutant form results in decreased expression of GCLC mRNA] | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:619868 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GCLC mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15328365 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15328365 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:15800033 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:19933214 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:619868 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:16960034 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of GCLC mRNA | CTD | PMID:16960034 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GCLC mRNA | CTD | PMID:20702594 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:619868 | 6480464 | 2,4-dinitrotoluene affects the expression of GCLC mRNA | CTD | PMID:21346803 |
| 2,6-di-tert-butyl-4-methylphenol | increases expression | ISO | RGD:10652 | 6480464 | Butylated Hydroxytoluene results in increased expression of GCLC protein | CTD | PMID:21536018 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:619868 | 6480464 | 2,6-dinitrotoluene affects the expression of GCLC mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:619868 | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCLC mRNA | CTD | PMID:14656948 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:619868 | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA | CTD | PMID:16158176 |
| 2-acetamidofluorene | increases expression | ISO | RGD:10652 | 6480464 | 2-Acetylaminofluorene results in increased expression of GCLC mRNA | CTD | PMID:16426233 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:10652 | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
| 2-butoxyethanol | increases expression | ISO | RGD:10652 | 6480464 | n-butoxyethanol results in increased expression of GCLC mRNA | CTD | PMID:19812364 |
| 2-nitrofluorene | increases expression | ISO | RGD:619868 | 6480464 | 2-nitrofluorene results in increased expression of GCLC mRNA | CTD | PMID:14600272 PMID:15890375 |
| 2-nitrofluorene | increases expression | ISO | RGD:619868 | 6480464 | 2-nitrofluorene results in increased expression of GCLC mRNA | CTD | PMID:15890375 PMID:14600272 |
| 3,4-methylenedioxymethamphetamine | multiple interactions | ISO | RGD:619868 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforafan results in increased expression of GCLC mRNA] | CTD | PMID:21871945 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:10652 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA; more ... | CTD | PMID:16054899 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:10652 | 6480464 | 1,2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:18367636 PMID:22959925 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:19073213 PMID:19408115 |
| 3H-1,2-dithiole-3-thione | increases expression | EXP | | 6480464 | 1,2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:19073213 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:10652 | 6480464 | 1,2-dithiol-3-thione results in increased expression of GCLC mRNA; more ... | CTD | PMID:18367636 |
| 3H-1,2-dithiole-3-thione | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 gene mutant form inhibits the reaction [1,2-dithiol-3-thione results in increased expression of GCLC protein]; more ... | CTD | PMID:18367636 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:619868 | 6480464 | 1,2-dithiol-3-thione results in increased expression of GCLC mRNA | CTD | PMID:15946642 |
| 3H-1,2-dithiole-3-thione | increases activity | ISO | RGD:619868 | 6480464 | 1,2-dithiol-3-thione results in increased activity of GCLC protein | CTD | PMID:12535742 |
| 3H-1,2-dithiole-3-thione | multiple interactions | ISO | RGD:619868 | 6480464 | [1,2-dithiol-3-thione results in increased activity of GCLC protein] which results in decreased susceptibility to Acrolein | CTD | PMID:12535742 |
| 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | RGD:619868 | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
| 4-hydroxynon-2-enal | increases expression | ISO | RGD:10652 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of GCLC mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | multiple interactions | EXP | | 6480464 | [Fenretinide co-treated with scriptaid] results in increased expression of GCLC mRNA; more ... | CTD | PMID:21319187 |
| 4-hydroxyphenyl retinamide | increases expression | EXP | | 6480464 | Fenretinide results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
| acetaldehyde | increases expression | ISO | RGD:619868 | 6480464 | Acetaldehyde results in increased expression of GCLC mRNA | CTD | PMID:11439094 |
| acetylcholine | decreases response to substance | EXP | | 6480464 | GCLC promoter SNP results in decreased susceptibility to Acetylcholine | CTD | PMID:12598062 |
| acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of GCLC mRNA | CTD | PMID:12084617 |
| acrolein | multiple interactions | ISO | RGD:619868 | 6480464 | [1,2-dithiol-3-thione results in increased activity of GCLC protein] which results in decreased susceptibility to Acrolein | CTD | PMID:12535742 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] | CTD | PMID:11972604 |
| aflatoxin B1 | increases expression | ISO | RGD:619868 | 6480464 | Aflatoxin B1 results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
| aflatoxin B1 | increases expression | ISO | RGD:10652 | 6480464 | Aflatoxin B1 results in increased expression of GCLC mRNA | CTD | PMID:19770486 |
| alachlor | increases expression | ISO | RGD:619868 | 6480464 | alachlor results in increased expression of GCLC protein | CTD | PMID:14563481 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:10652 | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
| alpha-hexylcinnamaldehyde | increases expression | EXP | | 6480464 | hexyl cinnamic aldehyde results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| alpha-linolenic acid | increases activity | EXP | | 6480464 | alpha-Linolenic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
| alpha-linolenic acid | increases expression | EXP | | 6480464 | alpha-Linolenic Acid results in increased expression of GCLC mRNA | CTD | PMID:17092368 |
| ampicillin | decreases expression | EXP | | 6480464 | Ampicillin results in decreased expression of GCLC mRNA | CTD | PMID:21632981 |
| antimony(0) | multiple interactions | EXP | | 6480464 | GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony] | CTD | PMID:11560771 |
| apigenin | increases expression | ISO | RGD:619868 | 6480464 | Apigenin results in increased expression of GCLC mRNA; more ... | CTD | PMID:22864849 |
| apigenin | multiple interactions | ISO | RGD:619868 | 6480464 | [Apigenin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:22864849 |
| apigenin | increases expression | EXP | | 6480464 | Apigenin results in increased expression of GCLC mRNA | CTD | PMID:11864778 |
| arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid results in increased expression of GCLC mRNA | CTD | PMID:17092368 PMID:16704987 |
| arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid results in increased expression of GCLC mRNA | CTD | PMID:16704987 PMID:17092368 |
| arachidonic acid | increases activity | EXP | | 6480464 | Arachidonic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of GCLC mRNA | CTD | PMID:19945496 |
| arsenic atom | increases expression | ISO | RGD:10652 | 6480464 | Arsenic results in increased expression of GCLC mRNA | CTD | PMID:23000044 |
| arsenic atom | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 mRNA affects the reaction [Arsenic results in increased expression of GCLC mRNA] | CTD | PMID:23000044 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of GCLC protein | CTD | PMID:18487201 |
| arsenite(3-) | multiple interactions | ISO | RGD:10652 | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLC mRNA]; more ... | CTD | PMID:19328227 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | KEAP1 protein affects the reaction [arsenite results in increased expression of GCLC mRNA]; more ... | CTD | PMID:22476201 |
| arsenite(3-) | increases expression | EXP | | 6480464 | arsenite results in increased expression of GCLC mRNA; more ... | CTD | PMID:22476201 |
| arsenite(3-) | increases expression | ISO | RGD:10652 | 6480464 | arsenite results in increased expression of GCLC mRNA | CTD | PMID:15894712 PMID:19328227 |
| arsenite(3-) | increases expression | ISO | RGD:10652 | 6480464 | arsenite results in increased expression of GCLC protein | CTD | PMID:19328227 |
| arsenite(3-) | multiple interactions | ISO | RGD:10652 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLC mRNA | CTD | PMID:15894712 |
| arsenite(3-) | increases expression | ISO | RGD:10652 | 6480464 | arsenite results in increased expression of GCLC mRNA | CTD | PMID:19328227 PMID:15894712 |
| Bandrowski's base | increases expression | EXP | | 6480464 | Bandrowski's base results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| benzene | affects expression | ISO | RGD:619868 | 6480464 | Benzene affects the expression of GCLC mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20713471 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:15034205 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:15894712 more ... |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10652 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of GCLC mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10652 | 6480464 | [arsenite co-treated with Benzo(a)pyrene] results in increased expression of GCLC mRNA | CTD | PMID:15894712 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20106945 |
| benzo[a]pyrene | increases expression | ISO | RGD:10652 | 6480464 | Benzo(a)pyrene results in increased expression of GCLC mRNA | CTD | PMID:20713471 more ... |
| benzoic acid | increases expression | EXP | | 6480464 | Benzoic Acid results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| beta-D-glucosamine | increases expression | ISO | RGD:10652 | 6480464 | Glucosamine analog results in increased expression of GCLC mRNA | CTD | PMID:21825963 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of GCLC mRNA | CTD | PMID:20170705 |
| bromobenzene | increases expression | ISO | RGD:10652 | 6480464 | bromobenzene results in increased expression of GCLC protein | CTD | PMID:18078705 |
| cadmium atom | increases expression | ISO | RGD:619868 | 6480464 | Cadmium results in increased expression of GCLC | CTD | PMID:19879314 |
| cadmium atom | multiple interactions | EXP | | 6480464 | [GCLC results in decreased uptake of Cadmium] which results in decreased expression of SLC39A8 | CTD | PMID:18556457 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC results in decreased susceptibility to Cadmium Chloride]; more ... | CTD | PMID:18556457 |
| cadmium dichloride | increases expression | ISO | RGD:10652 | 6480464 | Cadmium Chloride results in increased expression of GCLC mRNA | CTD | PMID:22677785 |
| cadmium dichloride | multiple interactions | ISO | RGD:619868 | 6480464 | GCLC affects the reaction [NFE2L2 protein results in decreased susceptibility to Cadmium Chloride] | CTD | PMID:19682480 |
| cadmium dichloride | increases expression | ISO | RGD:619868 | 6480464 | Cadmium Chloride results in increased expression of GCLC mRNA | CTD | PMID:11254161 |
| cadmium dichloride | multiple interactions | ISO | RGD:619868 | 6480464 | Cadmium Chloride results in increased expression of and results in increased activity of GCLC protein | CTD | PMID:11254161 |
| cadmium dichloride | decreases uptake | EXP | | 6480464 | GCLC results in decreased uptake of Cadmium Chloride | CTD | PMID:18556457 |
| cadmium dichloride | decreases response to substance | EXP | | 6480464 | GCLC results in decreased susceptibility to Cadmium Chloride | CTD | PMID:18556457 |
| cadmium sulfate | multiple interactions | EXP | | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GCLC mRNA | CTD | PMID:18654764 |
| cadmium sulfate | increases expression | ISO | RGD:10652 | 6480464 | cadmium sulfate results in increased expression of GCLC mRNA | CTD | PMID:16221973 |
| cadmium sulfate | increases expression | EXP | | 6480464 | cadmium sulfate results in increased expression of GCLC mRNA | CTD | PMID:12064557 |
| calcitriol | multiple interactions | ISO | RGD:619868 | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
| calcium atom | multiple interactions | ISO | RGD:619868 | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
| calcium(0) | multiple interactions | ISO | RGD:619868 | 6480464 | [Calcium co-treated with Calcitriol] affects the expression of GCLC mRNA | CTD | PMID:15913539 |
| carmustine | multiple interactions | ISO | RGD:619868 | 6480464 | [Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GCLC protein | CTD | PMID:12967637 |
| carmustine | multiple interactions | ISO | RGD:619868 | 6480464 | [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of GCLC protein | CTD | PMID:16288907 |
| carnosic acid | increases expression | ISO | RGD:10652 | 6480464 | salvin results in increased expression of GCLC mRNA | CTD | PMID:18329808 |
| chlorambucil | multiple interactions | EXP | | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Chlorambucil | CTD | PMID:10900222 |
| chloroprene | increases expression | ISO | RGD:619868 | 6480464 | Chloroprene results in increased expression of GCLC mRNA | CTD | PMID:23125180 |
| chloroprene | increases expression | ISO | RGD:10652 | 6480464 | Chloroprene results in increased expression of GCLC mRNA | CTD | PMID:23125180 |
| choline | multiple interactions | ISO | RGD:10652 | 6480464 | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA; more ... | CTD | PMID:20350562 |
| chromium(6+) | multiple interactions | ISO | RGD:10652 | 6480464 | [Arsenates co-treated with chromium hexavalent ion] results in increased expression of GCLC mRNA | CTD | PMID:19895865 |
| cinnamyl alcohol | increases expression | EXP | | 6480464 | cinnamyl alcohol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| ciprofibrate | decreases activity | ISO | RGD:619868 | 6480464 | ciprofibrate results in decreased activity of GCLC protein | CTD | PMID:7676460 |
| ciprofibrate | decreases expression | ISO | RGD:619868 | 6480464 | ciprofibrate results in decreased expression of GCLC mRNA | CTD | PMID:7676460 |
| cisplatin | multiple interactions | EXP | | 6480464 | Cisplatin promotes the reaction [MYC protein binds to GCLC promoter] | CTD | PMID:17628013 |
| cisplatin | increases expression | ISO | RGD:10652 | 6480464 | Cisplatin results in increased expression of GCLC protein; more ... | CTD | PMID:20605904 |
| cisplatin | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein promotes the reaction [Cisplatin results in increased expression of GCLC mRNA]; more ... | CTD | PMID:20605904 |
| cisplatin | increases phosphorylation | ISO | RGD:10652 | 6480464 | Cisplatin results in increased phosphorylation of GCLC protein | CTD | PMID:22006019 |
| clobetasol | decreases expression | EXP | | 6480464 | Clobetasol results in decreased expression of GCLC mRNA | CTD | PMID:16882163 |
| cobalt dichloride | multiple interactions | EXP | | 6480464 | [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GCLC mRNA | CTD | PMID:18654764 |
| cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of GCLC mRNA | CTD | PMID:19320972 |
| copper atom | decreases expression | ISO | RGD:619868 | 6480464 | Copper results in decreased expression of GCLC mRNA | CTD | PMID:22465980 |
| copper atom | multiple interactions | EXP | | 6480464 | N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of GCLC mRNA]; more ... | CTD | PMID:19747488 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GCLC mRNA | CTD | PMID:20971185 |
| copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of GCLC mRNA | CTD | PMID:19747488 |
| copper(0) | decreases expression | ISO | RGD:619868 | 6480464 | Copper results in decreased expression of GCLC mRNA | CTD | PMID:22465980 |
| copper(0) | multiple interactions | EXP | | 6480464 | N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide inhibits the reaction [Copper results in increased expression of GCLC mRNA]; more ... | CTD | PMID:19747488 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of GCLC mRNA | CTD | PMID:20971185 |
| copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of GCLC mRNA | CTD | PMID:19747488 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of GCLC mRNA | CTD | PMID:19549813 |
| copper(II) chloride | increases expression | EXP | | 6480464 | cupric chloride results in increased expression of GCLC mRNA | CTD | PMID:17211630 |
| cortisol | increases expression | ISO | RGD:619868 | 6480464 | Hydrocortisone results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
| coumarin | increases expression | ISO | RGD:619868 | 6480464 | coumarin results in increased expression of GCLC mRNA | CTD | PMID:18480146 |
| crocidolite asbestos | increases expression | ISO | RGD:10652 | 6480464 | Asbestos, Crocidolite results in increased expression of GCLC mRNA; more ... | CTD | PMID:15520183 |
| crocidolite asbestos | multiple interactions | ISO | RGD:10652 | 6480464 | [GCLC protein co-treated with GCLM protein] inhibits the reaction [Asbestos, Crocidolite results in increased expression of FOSL1 mRNA]; more ... | CTD | PMID:15520183 |
| curcumin | increases activity | EXP | | 6480464 | Curcumin results in increased activity of GCLC protein | CTD | PMID:10514034 |
| curcumin | increases expression | ISO | RGD:10652 | 6480464 | Curcumin results in increased expression of GCLC mRNA | CTD | PMID:19183254 PMID:19168576 |
| curcumin | increases expression | ISO | RGD:619868 | 6480464 | Curcumin results in increased expression of GCLC protein | CTD | PMID:18332871 PMID:17602960 |
| curcumin | increases expression | ISO | RGD:619868 | 6480464 | Curcumin results in increased expression of GCLC mRNA | CTD | PMID:18299980 PMID:17602960 |
| curcumin | increases expression | ISO | RGD:619868 | 6480464 | Curcumin results in increased expression of GCLC protein | CTD | PMID:17602960 PMID:18332871 |
| curcumin | increases expression | ISO | RGD:619868 | 6480464 | Curcumin results in increased expression of GCLC mRNA | CTD | PMID:17602960 PMID:18299980 |
| curcumin | multiple interactions | ISO | RGD:619868 | 6480464 | Curcumin results in increased activity of [GCLC protein binds to GCLM protein] | CTD | PMID:17602960 |
| curcumin | increases expression | ISO | RGD:10652 | 6480464 | Curcumin results in increased expression of GCLC mRNA | CTD | PMID:19168576 PMID:19183254 |
| cycloheximide | multiple interactions | ISO | RGD:10652 | 6480464 | Cycloheximide inhibits the reaction [arsenite results in increased activity of [GCLC protein binds to GCLM protein]]; more ... | CTD | PMID:19328227 |
| cycloheximide | multiple interactions | ISO | RGD:10652 | 6480464 | Cycloheximide inhibits the reaction [diphenylarsinic acid results in increased expression of GCLC protein] | CTD | PMID:17628625 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GCLC mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GCLC mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | decreases expression | ISO | RGD:619868 | 6480464 | Cyclosporine results in decreased expression of GCLC mRNA | CTD | PMID:11589784 |
| cysteamine | decreases activity | ISO | RGD:10652 | 6480464 | Cysteamine results in decreased activity of GCLC protein | CTD | PMID:15282320 |
| cysteamine | multiple interactions | ISO | RGD:10652 | 6480464 | [Cysteamine results in decreased activity of GCLC protein] which results in decreased abundance of Glutathione | CTD | PMID:15282320 |
| dexamethasone | multiple interactions | ISO | RGD:10652 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA] | CTD | PMID:16054899 |
| diarsenic trioxide | decreases response to substance | EXP | | 6480464 | GCLC protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of GCLC mRNA | CTD | PMID:19417148 PMID:22521957 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of GCLC mRNA | CTD | PMID:19417148 |
| diazoxide | decreases expression | ISO | RGD:10652 | 6480464 | Isoproterenol results in decreased expression of GCLC mRNA | CTD | PMID:21335049 |
| dibutyl phthalate | increases expression | ISO | RGD:619868 | 6480464 | Dibutyl Phthalate results in increased expression of GCLC mRNA | CTD | PMID:21266533 |
| diclofenac | decreases expression | ISO | RGD:619868 | 6480464 | Diclofenac results in decreased expression of GCLC mRNA | CTD | PMID:17202759 |
| diclofenac | affects response to substance | ISO | RGD:619868 | 6480464 | GCLC protein affects the susceptibility to Diclofenac | CTD | PMID:19481141 |
| diethyl maleate | increases expression | ISO | RGD:619868 | 6480464 | diethyl maleate results in increased expression of GCLC mRNA | CTD | PMID:10978506 PMID:15115889 |
| diethyl maleate | increases expression | ISO | RGD:619868 | 6480464 | diethyl maleate results in increased expression of GCLC protein | CTD | PMID:15115889 PMID:21465251 |
| diethyl maleate | increases expression | ISO | RGD:10652 | 6480464 | diethyl maleate results in increased expression of GCLC protein; more ... | CTD | PMID:10915739 |
| diethyl maleate | increases activity | ISO | RGD:10652 | 6480464 | diethyl maleate results in increased activity of GCLC protein | CTD | PMID:10915739 |
| diethyl maleate | increases activity | ISO | RGD:619868 | 6480464 | diethyl maleate results in increased activity of GCLC protein | CTD | PMID:15115889 |
| diethyl maleate | increases expression | ISO | RGD:619868 | 6480464 | diethyl maleate results in increased expression of GCLC protein | CTD | PMID:15115889 |
| diethylstilbestrol | increases expression | ISO | RGD:619868 | 6480464 | Diethylstilbestrol results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
| diquat | increases expression | ISO | RGD:10652 | 6480464 | Diquat results in increased expression of GCLC mRNA | CTD | PMID:16962985 |
| diquat | decreases activity | ISO | RGD:619868 | 6480464 | Diquat results in decreased activity of GCLC protein | CTD | PMID:7676460 |
| diquat | decreases expression | ISO | RGD:619868 | 6480464 | Diquat results in decreased expression of GCLC mRNA | CTD | PMID:7676460 |
| disodium selenite | increases expression | ISO | RGD:10652 | 6480464 | Sodium Selenite results in increased expression of GCLC mRNA | CTD | PMID:18449455 |
| disulfiram | increases expression | EXP | | 6480464 | Disulfiram results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| diuron | increases expression | ISO | RGD:619868 | 6480464 | Diuron results in increased expression of GCLC mRNA | CTD | PMID:21551480 |
| doxorubicin | multiple interactions | ISO | RGD:619868 | 6480464 | Doxorubicin promotes the reaction [tyrphostin AG 1478 results in decreased expression of GCLC protein] | CTD | PMID:18371937 |
| doxorubicin | decreases expression | ISO | RGD:619868 | 6480464 | Doxorubicin results in decreased expression of GCLC protein | CTD | PMID:9102927 PMID:18371937 |
| doxorubicin | decreases expression | ISO | RGD:619868 | 6480464 | Doxorubicin results in decreased expression of GCLC protein | CTD | PMID:18371937 PMID:9102927 |
| doxorubicin | multiple interactions | EXP | | 6480464 | GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:11560771 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [GSTP1 protein results in decreased susceptibility to Doxorubicin] | CTD | PMID:10900222 |
| elemental selenium | multiple interactions | ISO | RGD:619868 | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA | CTD | PMID:11444866 |
| ethacrynic acid | multiple interactions | EXP | | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Ethacrynic Acid | CTD | PMID:10900222 |
| ethanol | increases expression | ISO | RGD:619868 | 6480464 | Ethanol results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of GCLC mRNA | CTD | PMID:19133322 |
| ethanol | multiple interactions | EXP | | 6480464 | CYP2E1 protein promotes the reaction [Ethanol results in increased expression of GCLC mRNA] | CTD | PMID:19133322 |
| etoposide | multiple interactions | EXP | | 6480464 | [GCLC protein co-treated with GCLM protein] promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide]; more ... | CTD | PMID:10900222 |
| eugenol | increases expression | EXP | | 6480464 | Eugenol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| farnesal | increases expression | EXP | | 6480464 | farnesal results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
| flutamide | increases expression | ISO | RGD:10652 | 6480464 | Flutamide results in increased expression of GCLC mRNA | CTD | PMID:17702527 |
| flutamide | affects response to substance | ISO | RGD:619868 | 6480464 | GCLC protein affects the susceptibility to Flutamide | CTD | PMID:19481141 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
| gamma-linolenic acid | increases expression | EXP | | 6480464 | gamma-Linolenic Acid results in increased expression of GCLC mRNA | CTD | PMID:17092368 |
| gamma-linolenic acid | increases activity | EXP | | 6480464 | gamma-Linolenic Acid results in increased activity of GCLC protein | CTD | PMID:17092368 |
| gefitinib | affects response to substance | EXP | | 6480464 | GCLC protein affects the susceptibility to gefitinib | CTD | PMID:15496427 |
| genistein | multiple interactions | ISO | RGD:619868 | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
| genistein | increases expression | ISO | RGD:619868 | 6480464 | Genistein results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
| gliclazide | multiple interactions | ISO | RGD:619868 | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; more ... | CTD | PMID:21439372 |
| glutathione | increases abundance | ISO | RGD:10652 | 6480464 | GCLC protein results in increased abundance of Glutathione | CTD | PMID:19914271 PMID:7955076 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | GCLC protein inhibits the reaction [Hydrogen Peroxide results in decreased abundance of Glutathione] | CTD | PMID:19914271 |
| glutathione | increases abundance | ISO | RGD:10652 | 6480464 | GCLC protein results in increased abundance of Glutathione | CTD | PMID:19914271 |
| glutathione | increases expression | ISO | RGD:619868 | 6480464 | Glutathione deficiency results in increased expression of GCLC mRNA | CTD | PMID:15345336 PMID:20621112 |
| glutathione | affects chemical synthesis | EXP | | 6480464 | GCLC polymorphism affects the chemical synthesis of Glutathione | CTD | PMID:16599007 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | [Buthionine Sulfoximine results in decreased activity of GCLC protein] which results in decreased abundance of Glutathione | CTD | PMID:15707499 |
| glutathione | multiple interactions | EXP | | 6480464 | [GCLC results in increased abundance of Glutathione] which results in decreased susceptibility to Cadmium Chloride | CTD | PMID:18556457 |
| glutathione | increases abundance | EXP | | 6480464 | GCLC results in increased abundance of Glutathione | CTD | PMID:18556457 |
| glutathione | multiple interactions | EXP | | 6480464 | [[Glutathione deficiency results in increased abundance of Reactive Oxygen Species] which results in increased activity of NFE2L2 protein] which results in increased expression of GCLC protein; more ... | CTD | PMID:21728338 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | [Cysteamine results in decreased activity of GCLC protein] which results in decreased abundance of Glutathione | CTD | PMID:15282320 |
| glutathione | multiple interactions | ISO | RGD:619868 | 6480464 | [HGF protein results in increased activity of GCLC protein] which results in increased chemical synthesis of Glutathione | CTD | PMID:10544272 |
| glutathione | increases expression | ISO | RGD:619868 | 6480464 | Glutathione deficiency results in increased expression of GCLC mRNA | CTD | PMID:15345336 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | GCLC protein inhibits the reaction [IKBKB protein mutant form results in decreased abundance of Glutathione] | CTD | PMID:20159942 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | GCLC protein affects the reaction [RXRA protein affects the abundance of Glutathione] | CTD | PMID:14978233 |
| glutathione | multiple interactions | EXP | | 6480464 | [KLF4 results in increased expression of GCLC mRNA] which results in increased abundance of Glutathione | CTD | PMID:21833590 |
| glutathione | multiple interactions | EXP | | 6480464 | GCLC protein inhibits the reaction [buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione]] | CTD | PMID:12504668 |
| glutathione | multiple interactions | EXP | | 6480464 | [Ginkgo biloba extract 761 results in increased expression of GCLC protein] which results in increased chemical synthesis of Glutathione | CTD | PMID:11673643 |
| glutathione | multiple interactions | ISO | RGD:10652 | 6480464 | [Buthionine Sulfoximine results in decreased activity of GCLC protein] inhibits the reaction [indenoindole results in increased abundance of Glutathione]; more ... | CTD | PMID:7955076 |
| hemin | increases expression | EXP | | 6480464 | Hemin results in increased expression of GCLC mRNA | CTD | PMID:16631525 |
| hexane | increases expression | EXP | | 6480464 | n-hexane results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of GCLC mRNA | CTD | PMID:16631525 PMID:12598062 |
| hydrogen peroxide | multiple interactions | ISO | RGD:10652 | 6480464 | GCLC protein inhibits the reaction [Hydrogen Peroxide results in decreased abundance of Glutathione] | CTD | PMID:19914271 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:10652 | 6480464 | GCLC protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:19914271 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of GCLC mRNA | CTD | PMID:12598062 PMID:16631525 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of GCLC mRNA | CTD | PMID:20044591 |
| hypochlorous acid | multiple interactions | ISO | RGD:10652 | 6480464 | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA]; more ... | CTD | PMID:17980396 |
| hypochlorous acid | affects expression | ISO | RGD:10652 | 6480464 | Hypochlorous Acid affects the expression of GCLC mRNA | CTD | PMID:18648578 |
| hypochlorous acid | increases expression | ISO | RGD:10652 | 6480464 | Hypochlorous Acid results in increased expression of GCLC mRNA | CTD | PMID:17980396 |
| ibuprofen | increases expression | EXP | | 6480464 | Ibuprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| indomethacin | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA]; more ... | CTD | PMID:11909699 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of GCLC protein | CTD | PMID:11820781 |
| iron atom | increases activity | ISO | RGD:619868 | 6480464 | Iron results in increased activity of GCLC protein | CTD | PMID:17189828 |
| iron atom | decreases expression | EXP | | 6480464 | Iron results in decreased expression of GCLC mRNA | CTD | PMID:19073151 |
| iron atom | multiple interactions | EXP | | 6480464 | Ursodeoxycholic Acid inhibits the reaction [Iron results in decreased expression of GCLC mRNA] | CTD | PMID:19073151 |
| iron trichloride | multiple interactions | ISO | RGD:10652 | 6480464 | [ferric chloride co-treated with TNF protein] results in increased expression of GCLC protein | CTD | PMID:19900513 |
| isoeugenol | increases expression | EXP | | 6480464 | isoeugenol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| isoprenaline | decreases expression | ISO | RGD:10652 | 6480464 | Isoproterenol results in decreased expression of GCLC mRNA | CTD | PMID:21335049 |
| kaempferol | increases expression | EXP | | 6480464 | kaempferol results in increased expression of GCLC mRNA | CTD | PMID:11864778 |
| ketamine | increases expression | ISO | RGD:619868 | 6480464 | Ketamine results in increased expression of GCLC mRNA | CTD | PMID:20080153 |
| ketoprofen | increases expression | EXP | | 6480464 | Ketoprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| L-cysteine | multiple interactions | ISO | RGD:619868 | 6480464 | Cysteine promotes the reaction [GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine] | CTD | PMID:15115889 |
| L-gamma-glutamyl-L-cysteine | multiple interactions | ISO | RGD:619868 | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine]; more ... | CTD | PMID:15115889 |
| L-gamma-glutamyl-L-cysteine | increases chemical synthesis | ISO | RGD:619868 | 6480464 | GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine | CTD | PMID:15115889 |
| L-methionine | multiple interactions | ISO | RGD:10652 | 6480464 | [Choline deficiency co-treated with Methionine deficiency] results in increased expression of GCLC mRNA; more ... | CTD | PMID:20350562 |
| lactic acid | increases expression | EXP | | 6480464 | Lactic Acid results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| linalool | increases expression | EXP | | 6480464 | linalool results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
| lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:16249512 PMID:17940886 |
| lipoic acid | increases expression | EXP | | 6480464 | Thioctic Acid results in increased expression of GCLC mRNA | CTD | PMID:17940886 PMID:16249512 |
| lithocholic acid | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein promotes the reaction [Lithocholic Acid results in increased expression of GCLC protein]; more ... | CTD | PMID:20977460 |
| lithocholic acid | increases expression | ISO | RGD:10652 | 6480464 | Lithocholic Acid results in increased expression of GCLC protein; more ... | CTD | PMID:20977460 |
| luteolin | increases expression | ISO | RGD:619868 | 6480464 | Luteolin results in increased expression of GCLC mRNA; more ... | CTD | PMID:22864849 |
| luteolin | multiple interactions | ISO | RGD:619868 | 6480464 | [Luteolin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:22864849 |
| LY294002 | decreases expression | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of GCLC mRNA | CTD | PMID:19073151 |
| LY294002 | multiple interactions | ISO | RGD:619868 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Plant Extracts results in increased expression of GCLC mRNA] | CTD | PMID:20399244 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA] | CTD | PMID:19073151 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cinnamic aldehyde results in increased expression of GCLC protein] | CTD | PMID:21469739 |
| maneb | increases expression | EXP | | 6480464 | [Maneb results in increased expression of NFE2L2 protein] which results in increased expression of GCLC mRNA | CTD | PMID:21402726 |
| maneb | increases activity | ISO | RGD:619868 | 6480464 | Maneb results in increased activity of GCLC protein | CTD | PMID:15527874 |
| menadione | increases activity | EXP | | 6480464 | Vitamin K 3 results in increased activity of GCLC protein | CTD | PMID:11972604 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of GCLC mRNA | CTD | PMID:11972604 |
| menadione | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [Vitamin K 3 results in increased expression of GCLC mRNA] | CTD | PMID:11972604 |
| mercury atom | increases expression | EXP | | 6480464 | Mercury results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
| mercury atom | multiple interactions | EXP | | 6480464 | GCLC gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury] | CTD | PMID:19515364 |
| mercury atom | affects response to substance | EXP | | 6480464 | GCLC gene SNP affects the susceptibility to Mercury | CTD | PMID:22236634 |
| mercury(0) | increases expression | EXP | | 6480464 | Mercury results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
| mercury(0) | multiple interactions | EXP | | 6480464 | GCLC gene polymorphism promotes the reaction [GSTP1 gene polymorphism affects the abundance of Mercury] | CTD | PMID:19515364 |
| mercury(0) | affects response to substance | EXP | | 6480464 | GCLC gene SNP affects the susceptibility to Mercury | CTD | PMID:22236634 |
| methapyrilene | increases expression | ISO | RGD:619868 | 6480464 | Methapyrilene results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
| methapyrilene | increases expression | ISO | RGD:619868 | 6480464 | Methapyrilene results in increased expression of GCLC protein | CTD | PMID:19523481 |
| methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of GCLC mRNA | CTD | PMID:20144635 |
| methotrexate | affects expression | ISO | RGD:10652 | 6480464 | Methotrexate affects the expression of GCLC mRNA | CTD | PMID:18502557 |
| methoxychlor | multiple interactions | ISO | RGD:619868 | 6480464 | [Genistein co-treated with Methoxychlor] results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
| methoxychlor | increases expression | ISO | RGD:619868 | 6480464 | Methoxychlor results in increased expression of GCLC mRNA | CTD | PMID:21782745 |
| methyl non-2-ynoate | increases expression | EXP | | 6480464 | 2-nonynoic acid methyl ester results in increased expression of GCLC mRNA | CTD | PMID:20491607 |
| methyl salicylate | increases expression | EXP | | 6480464 | methyl salicylate results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| methylmercury chloride | increases expression | ISO | RGD:10652 | 6480464 | methylmercuric chloride results in increased expression of GCLC mRNA | CTD | PMID:20061341 |
| microcystin-LR | increases expression | ISO | RGD:10652 | 6480464 | cyanoginosin LR results in increased expression of GCLC mRNA | CTD | PMID:17654400 |
| mifepristone | multiple interactions | ISO | RGD:10652 | 6480464 | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]] | CTD | PMID:16840778 |
| mifepristone | increases expression | ISO | RGD:10652 | 6480464 | Mifepristone results in increased expression of GCLC protein | CTD | PMID:16840778 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Indomethacin results in increased expression of GCLC mRNA] | CTD | PMID:11909699 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Paraquat results in decreased expression of GCLC protein] | CTD | PMID:20851755 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of GCLC protein] | CTD | PMID:21728338 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:619868 | 6480464 | Acetylcysteine inhibits the reaction [decamethrin results in increased expression of GCLC mRNA]; more ... | CTD | PMID:17540521 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein] | CTD | PMID:11820781 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10652 | 6480464 | Acetylcysteine inhibits the reaction [arsenite results in increased expression of GCLC mRNA] | CTD | PMID:19328227 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:10652 | 6480464 | Acetylcysteine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA] | CTD | PMID:17980396 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [3-O-caffeoyl-1-methylquinic acid results in increased expression of GCLC mRNA] | CTD | PMID:16631525 |
| N-methylformamide | affects expression | ISO | RGD:10652 | 6480464 | methylformamide affects the expression of GCLC mRNA; more ... | CTD | PMID:17040096 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:619868 | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased expression of GCLC mRNA | CTD | PMID:16158176 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:619868 | 6480464 | Diethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:619868 | 6480464 | [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased expression of GCLC mRNA | CTD | PMID:14656948 |
| N-nitrosodimethylamine | increases expression | EXP | | 6480464 | Dimethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:619868 | 6480464 | Dimethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:15890375 PMID:14600272 |
| N-nitrosodimethylamine | increases expression | ISO | RGD:619868 | 6480464 | Dimethylnitrosamine results in increased expression of GCLC mRNA | CTD | PMID:14600272 PMID:15890375 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | increases expression | ISO | RGD:10652 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone results in increased expression of GCLC mRNA | CTD | PMID:22851183 |
| naphthalene | multiple interactions | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in decreased susceptibility to naphthalene]; more ... | CTD | PMID:12805647 |
| naphthalene | decreases response to substance | ISO | RGD:10652 | 6480464 | GCLC protein results in decreased susceptibility to naphthalene | CTD | PMID:12805647 PMID:10900227 |
| naphthalene | increases activity | ISO | RGD:10652 | 6480464 | naphthalene results in increased activity of GCLC protein | CTD | PMID:10900227 |
| naphthalene | decreases response to substance | ISO | RGD:10652 | 6480464 | GCLC protein results in decreased susceptibility to naphthalene | CTD | PMID:10900227 PMID:12805647 |
| naphthalene | multiple interactions | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine inhibits the reaction [naphthalene results in increased activity of GCLC protein] | CTD | PMID:10900227 |
| naproxen | increases expression | EXP | | 6480464 | Naproxen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of GCLC mRNA | CTD | PMID:17547211 |
| nickel dichloride | increases expression | EXP | | 6480464 | nickel chloride results in increased expression of GCLC mRNA | CTD | PMID:17547211 PMID:21111804 |
| nickel dichloride | affects expression | ISO | RGD:619868 | 6480464 | nickel chloride affects the expression of GCLC mRNA | CTD | PMID:22110744 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:20491607 PMID:20566472 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:20566472 PMID:20491607 |
| nickel sulfate | increases expression | ISO | RGD:10652 | 6480464 | nickel sulfate results in increased expression of GCLC mRNA | CTD | PMID:16100012 |
| nicotinamide | multiple interactions | ISO | RGD:619868 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; more ... | CTD | PMID:21439372 |
| nitisinone | multiple interactions | ISO | RGD:10652 | 6480464 | [nitisinone results in decreased activity of HPD protein] which results in decreased expression of GCLC mRNA | CTD | PMID:12899938 |
| nitric oxide | decreases expression | ISO | RGD:619868 | 6480464 | Nitric Oxide deficiency results in decreased expression of GCLC mRNA; more ... | CTD | PMID:19631198 |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC protein; more ... | CTD | PMID:16251485 |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC mRNA | CTD | PMID:16251485 more ... |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC protein | CTD | PMID:17110534 PMID:16251485 |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC mRNA | CTD | PMID:16251485 PMID:18417182 |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC protein | CTD | PMID:16251485 PMID:17110534 |
| ochratoxin A | decreases expression | ISO | RGD:619868 | 6480464 | ochratoxin A results in decreased expression of GCLC mRNA | CTD | PMID:18417182 PMID:16251485 |
| ochratoxin A | multiple interactions | ISO | RGD:619868 | 6480464 | [cafestol co-treated with kahweol] inhibits the reaction [ochratoxin A results in decreased expression of GCLC protein] | CTD | PMID:17110534 |
| oleanolic acid | increases expression | ISO | RGD:619868 | 6480464 | Oleanolic Acid results in increased expression of GCLC mRNA | CTD | PMID:18706400 |
| oleanolic acid | increases expression | ISO | RGD:10652 | 6480464 | Oleanolic Acid results in increased expression of GCLC mRNA | CTD | PMID:18706400 PMID:19283895 |
| oleanolic acid | increases expression | ISO | RGD:10652 | 6480464 | Oleanolic Acid results in increased expression of GCLC mRNA | CTD | PMID:19283895 PMID:18706400 |
| ozone | multiple interactions | ISO | RGD:10652 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Ozone results in increased expression of GCLC mRNA] | CTD | PMID:17460151 |
| ozone | increases expression | ISO | RGD:10652 | 6480464 | Ozone results in increased expression of GCLC mRNA | CTD | PMID:17095637 |
| ozone | multiple interactions | ISO | RGD:10652 | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of GCLC mRNA] | CTD | PMID:19555225 |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:18078705 more ... |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11245408 more ... |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | [IL4 gene mutant form results in increased susceptibility to Acetaminophen] which affects the expression of GCLC mRNA; more ... | CTD | PMID:22107450 |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:10915739 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:10915739 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:17202758 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:18071297 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:18468992 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:19371629 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:17935745 more ... |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11779202 more ... |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:19371629 PMID:17935745 |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:18468992 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:10915739 more ... |
| paracetamol | affects expression | ISO | RGD:10652 | 6480464 | Acetaminophen affects the expression of GCLC mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | affects response to substance | ISO | RGD:619868 | 6480464 | GCLC protein affects the susceptibility to Acetaminophen | CTD | PMID:17573345 |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11779202 more ... |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | Prazosin inhibits the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:18071297 |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of GCLC protein] | CTD | PMID:17935745 |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein affects the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:17935745 PMID:19371629 |
| paracetamol | decreases response to substance | ISO | RGD:10652 | 6480464 | GCLC protein results in decreased susceptibility to Acetaminophen | CTD | PMID:18642143 |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | [Acetaminophen results in increased activity of and results in increased localization of NFE2L2 protein] which results in increased expression of GCLC mRNA | CTD | PMID:15122755 |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:10915739 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:10915739 more ... |
| paracetamol | decreases activity | ISO | RGD:10652 | 6480464 | Acetaminophen results in decreased activity of GCLC protein | CTD | PMID:10915739 |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | Acetaminophen promotes the reaction [Mifepristone results in increased activity of [GCLC protein binds to GCLM protein]]; more ... | CTD | PMID:16840778 |
| paracetamol | multiple interactions | ISO | RGD:10652 | 6480464 | Acetaminophen promotes the reaction [1-(2-cyano-3,12-dioxooleana-1,9-dien-28-oyl) imidazole results in increased expression of GCLC mRNA]; more ... | CTD | PMID:19371629 |
| paracetamol | affects expression | ISO | RGD:10652 | 6480464 | Acetaminophen affects the expression of GCLC mRNA | CTD | PMID:17562736 PMID:15606129 |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:19103213 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:17935745 more ... |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11779202 more ... |
| paracetamol | increases expression | ISO | RGD:619868 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:11245408 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC protein | CTD | PMID:10915739 more ... |
| paracetamol | increases expression | ISO | RGD:10652 | 6480464 | Acetaminophen results in increased expression of GCLC mRNA | CTD | PMID:21672600 more ... |
| paraquat | increases expression | ISO | RGD:10652 | 6480464 | Paraquat results in increased expression of GCLC mRNA | CTD | PMID:17215068 |
| paraquat | decreases expression | EXP | | 6480464 | Paraquat results in decreased expression of GCLC protein | CTD | PMID:20851755 |
| paraquat | multiple interactions | EXP | | 6480464 | meloxicam inhibits the reaction [Paraquat results in decreased expression of GCLC protein]; more ... | CTD | PMID:20851755 |
| paraquat | affects expression | ISO | RGD:619868 | 6480464 | Paraquat affects the expression of GCLC mRNA | CTD | PMID:16854511 |
| phenethyl isothiocyanate | increases expression | EXP | | 6480464 | phenethyl isothiocyanate results in increased expression of GCLC mRNA | CTD | PMID:20442190 |
| phenobarbital | decreases expression | ISO | RGD:10652 | 6480464 | Phenobarbital results in decreased expression of GCLC mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | ISO | RGD:619868 | 6480464 | Phenobarbital results in decreased expression of GCLC mRNA | CTD | PMID:19162173 |
| phlorizin | decreases expression | ISO | RGD:10652 | 6480464 | Phlorhizin results in decreased expression of GCLC mRNA | CTD | PMID:22538082 |
| phloroglucinol | increases expression | ISO | RGD:10652 | 6480464 | Phloroglucinol results in increased expression of GCLC protein | CTD | PMID:20188716 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with rosuvastatin] results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10652 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCLC mRNA | CTD | PMID:17200146 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
| phosgene | affects expression | ISO | RGD:10652 | 6480464 | Phosgene affects the expression of GCLC mRNA | CTD | PMID:16300373 |
| piperonyl butoxide | increases expression | ISO | RGD:619868 | 6480464 | Piperonyl Butoxide results in increased expression of GCLC mRNA | CTD | PMID:15890375 |
| pirinixic acid | increases expression | ISO | RGD:619868 | 6480464 | pirinixic acid results in increased expression of GCLC mRNA | CTD | PMID:15890375 PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:619868 | 6480464 | pirinixic acid results in increased expression of GCLC mRNA | CTD | PMID:19162173 PMID:15890375 |
| pirinixic acid | increases expression | ISO | RGD:10652 | 6480464 | pirinixic acid results in increased expression of GCLC mRNA | CTD | PMID:17426115 |
| pirinixic acid | decreases expression | ISO | RGD:10652 | 6480464 | pirinixic acid results in decreased expression of GCLC mRNA | CTD | PMID:18445702 |
| prazosin | multiple interactions | ISO | RGD:10652 | 6480464 | Prazosin inhibits the reaction [Acetaminophen results in increased expression of GCLC mRNA] | CTD | PMID:18071297 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:619868 | 6480464 | Pregnenolone Carbonitrile results in increased expression of GCLC mRNA | CTD | PMID:19162173 |
| propan-2-ol | increases expression | EXP | | 6480464 | 2-Propanol results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| prostaglandin J2 | increases expression | ISO | RGD:619868 | 6480464 | 9-deoxy-delta-9-prostaglandin D2 results in increased expression of GCLC protein; more ... | CTD | PMID:18332871 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of GCLC mRNA | CTD | PMID:11864778 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of GCLC mRNA | CTD | PMID:11864778 more ... |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of GCLC mRNA | CTD | PMID:11864778 PMID:21256954 |
| quercetin | increases expression | ISO | RGD:619868 | 6480464 | Quercetin results in increased expression of GCLC mRNA | CTD | PMID:19798679 |
| quercetin | multiple interactions | ISO | RGD:619868 | 6480464 | Quercetin promotes the reaction [EGR1 protein binds to GCLC promoter] | CTD | PMID:19798679 |
| quercetin | increases expression | ISO | RGD:10652 | 6480464 | Quercetin results in increased expression of GCLC mRNA | CTD | PMID:19183254 |
| quercetin | affects expression | ISO | RGD:619868 | 6480464 | Quercetin affects the expression of GCLC mRNA | CTD | PMID:18178720 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 more ... |
| resveratrol | multiple interactions | ISO | RGD:619868 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; more ... | CTD | PMID:21439372 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 PMID:20418481 |
| resveratrol | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [resveratrol results in increased expression of GCLC mRNA]; more ... | CTD | PMID:20418481 |
| resveratrol | increases expression | ISO | RGD:619868 | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:15882976 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| resveratrol | increases expression | ISO | RGD:10652 | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:21520053 |
| resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of GCLC mRNA]; more ... | CTD | PMID:11909699 |
| rosiglitazone | multiple interactions | ISO | RGD:10652 | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of GCLC mRNA; more ... | CTD | PMID:16054899 |
| rosuvastatin | increases expression | EXP | | 6480464 | rosuvastatin results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
| rosuvastatin | multiple interactions | EXP | | 6480464 | [Tetradecanoylphorbol Acetate co-treated with rosuvastatin] results in increased expression of GCLC mRNA | CTD | PMID:18154958 |
| rotenone | increases expression | ISO | RGD:10652 | 6480464 | Rotenone results in increased expression of GCLC mRNA | CTD | PMID:17657281 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine results in decreased activity of GCLC protein | CTD | PMID:15707499 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:619868 | 6480464 | [Buthionine Sulfoximine results in decreased activity of [GCLC protein binds to GCLM protein]] inhibits the reaction [chrysin inhibits the reaction [tert-Butylhydroperoxide results in increased chemical synthesis of Reactive Oxygen Species]] | CTD | PMID:22864849 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | EXP | | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC results in decreased susceptibility to Cadmium Chloride] | CTD | PMID:18556457 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | [Buthionine Sulfoximine results in decreased activity of GCLC protein] which results in decreased abundance of Glutathione | CTD | PMID:15707499 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine results in increased expression of GCLC mRNA | CTD | PMID:18449455 PMID:17980396 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:619868 | 6480464 | [Carmustine co-treated with Buthionine Sulfoximine] results in decreased activity of GCLC protein | CTD | PMID:16288907 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:619868 | 6480464 | Buthionine Sulfoximine results in increased expression of GCLC mRNA | CTD | PMID:10978506 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | ISO | RGD:619868 | 6480464 | Buthionine Sulfoximine results in decreased activity of GCLC protein | CTD | PMID:12433058 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:619868 | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in increased chemical synthesis of gamma-glutamylcysteine] | CTD | PMID:15115889 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:619868 | 6480464 | [Buthionine Sulfoximine co-treated with Carmustine] results in decreased activity of GCLC protein | CTD | PMID:12967637 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | [Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein | CTD | PMID:11019651 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases expression | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine results in increased expression of GCLC mRNA | CTD | PMID:17980396 PMID:18449455 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | increases activity | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine results in increased activity of GCLC protein | CTD | PMID:10915739 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine inhibits the reaction [naphthalene results in increased activity of GCLC protein] | CTD | PMID:10900227 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine inhibits the reaction [Hypochlorous Acid results in increased expression of GCLC mRNA] | CTD | PMID:17980396 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine inhibits the reaction [GCLC protein results in decreased susceptibility to naphthalene] | CTD | PMID:12805647 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:10652 | 6480464 | [Buthionine Sulfoximine results in decreased activity of GCLC protein] inhibits the reaction [indenoindole results in increased abundance of Glutathione] | CTD | PMID:7955076 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases activity | ISO | RGD:10652 | 6480464 | Buthionine Sulfoximine results in decreased activity of GCLC protein | CTD | PMID:15707499 PMID:7955076 |
| selenium atom | multiple interactions | ISO | RGD:619868 | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of GCLC mRNA | CTD | PMID:11444866 |
| silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22079246 |
| silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 PMID:22546375 |
| silver atom | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLC mRNA] | CTD | PMID:22546375 |
| silver atom | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 |
| silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22079246 |
| silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 PMID:22546375 |
| silver(0) | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Silver results in increased expression of GCLC mRNA] | CTD | PMID:22546375 |
| silver(0) | increases expression | EXP | | 6480464 | Silver results in increased expression of GCLC mRNA | CTD | PMID:22036727 |
| silver(1+) nitrate | decreases expression | EXP | | 6480464 | Silver Nitrate results in decreased expression of GCLC mRNA | CTD | PMID:19733233 |
| sodium dichromate | increases expression | ISO | RGD:619868 | 6480464 | sodium bichromate results in increased expression of GCLC mRNA | CTD | PMID:22561333 |
| sodium dichromate | increases expression | ISO | RGD:10652 | 6480464 | sodium bichromate results in increased expression of GCLC mRNA | CTD | PMID:22155349 |
| sodium dichromate | decreases expression | ISO | RGD:10652 | 6480464 | sodium bichromate results in decreased expression of GCLC mRNA | CTD | PMID:22155349 |
| sodium dodecyl sulfate | increases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in increased expression of GCLC mRNA | CTD | PMID:20566472 |
| staurosporine | multiple interactions | EXP | | 6480464 | Staurosporine promotes the reaction [MYC protein binds to GCLC promoter] | CTD | PMID:17628013 |
| stavudine | increases expression | ISO | RGD:619868 | 6480464 | Stavudine results in increased expression of GCLC mRNA | CTD | PMID:18299183 |
| streptozocin | multiple interactions | ISO | RGD:619868 | 6480464 | Gliclazide inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC protein]; more ... | CTD | PMID:21439372 |
| styrene | increases activity | ISO | RGD:10652 | 6480464 | Styrene results in increased activity of GCLC protein | CTD | PMID:16971035 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:20442190 |
| sulforaphane | increases expression | ISO | RGD:619868 | 6480464 | sulforafan results in increased expression of GCLC protein | CTD | PMID:22558124 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of GCLC protein | CTD | PMID:22558124 |
| sulforaphane | increases expression | ISO | RGD:10652 | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:17942926 more ... |
| sulforaphane | increases expression | ISO | RGD:10652 | 6480464 | sulforafan results in increased expression of GCLC protein | CTD | PMID:19303893 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:20442190 PMID:21871945 |
| sulforaphane | increases expression | ISO | RGD:10652 | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:17942926 more ... |
| sulforaphane | increases expression | ISO | RGD:619868 | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:21871945 |
| sulforaphane | multiple interactions | ISO | RGD:619868 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine inhibits the reaction [sulforafan results in increased expression of GCLC mRNA] | CTD | PMID:21871945 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:21871945 PMID:20442190 |
| sulforaphane | multiple interactions | EXP | | 6480464 | alpha-methylepinine promotes the reaction [sulforafan results in increased expression of GCLC mRNA]; more ... | CTD | PMID:21871945 |
| sulforaphane | increases expression | ISO | RGD:10652 | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:20932822 PMID:17942926 |
| sulforaphane | increases expression | ISO | RGD:10652 | 6480464 | sulforafan results in increased expression of GCLC mRNA | CTD | PMID:17942926 PMID:20932822 |
| sulforaphane | multiple interactions | ISO | RGD:10652 | 6480464 | [sulforafan co-treated with dibenzoylmethane] results in increased expression of GCLC mRNA | CTD | PMID:17942926 |
| sulforaphane | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 protein promotes the reaction [sulforafan results in increased expression of GCLC mRNA] | CTD | PMID:20932822 |
| sulindac | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Sulindac results in increased expression of GCLC protein] | CTD | PMID:11820781 |
| sulindac | increases expression | EXP | | 6480464 | Sulindac results in increased expression of GCLC protein | CTD | PMID:11820781 |
| sulindac | affects expression | EXP | | 6480464 | Sulindac affects the expression of GCLC mRNA | CTD | PMID:15946948 |
| suprofen | increases expression | EXP | | 6480464 | Suprofen results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| tamoxifen | affects expression | ISO | RGD:10652 | 6480464 | Tamoxifen affects the expression of GCLC mRNA | CTD | PMID:20937368 |
| tert-butyl hydroperoxide | multiple interactions | EXP | | 6480464 | [Linoleic Acids, Conjugated results in increased activity of GCLC protein] which results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:17092368 |
| tert-butyl hydroperoxide | multiple interactions | ISO | RGD:619868 | 6480464 | [chrysin results in increased expression of GCLC mRNA] which results in decreased susceptibility to tert-Butylhydroperoxide; more ... | CTD | PMID:22864849 |
| tert-butyl hydroperoxide | decreases response to substance | ISO | RGD:619868 | 6480464 | GCLC protein results in decreased susceptibility to tert-Butylhydroperoxide | CTD | PMID:12425961 |
| tetrachloromethane | affects expression | ISO | RGD:10652 | 6480464 | Carbon Tetrachloride affects the expression of GCLC mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases expression | ISO | RGD:10652 | 6480464 | Carbon Tetrachloride results in increased expression of GCLC protein | CTD | PMID:18078705 PMID:10915739 |
| tetrachloromethane | increases expression | ISO | RGD:10652 | 6480464 | Carbon Tetrachloride results in increased expression of GCLC mRNA | CTD | PMID:10915739 |
| tetrachloromethane | increases expression | ISO | RGD:10652 | 6480464 | Carbon Tetrachloride results in increased expression of GCLC protein | CTD | PMID:10915739 PMID:18078705 |
| tetrachloromethane | decreases activity | ISO | RGD:10652 | 6480464 | Carbon Tetrachloride results in decreased activity of GCLC protein | CTD | PMID:10915739 |
| thiabendazole | increases activity | ISO | RGD:10652 | 6480464 | Thiabendazole results in increased activity of GCLC protein | CTD | PMID:11019651 |
| thiabendazole | multiple interactions | ISO | RGD:10652 | 6480464 | [Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein | CTD | PMID:11019651 |
| thioacetamide | increases expression | ISO | RGD:619868 | 6480464 | Thioacetamide results in increased expression of GCLC mRNA | CTD | PMID:10486302 PMID:10978506 |
| thioacetamide | increases expression | ISO | RGD:619868 | 6480464 | Thioacetamide results in increased expression of GCLC mRNA | CTD | PMID:10978506 PMID:10486302 |
| thioacetamide | increases expression | ISO | RGD:619868 | 6480464 | Thioacetamide results in increased expression of GCLC protein | CTD | PMID:10486302 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:619868 | 6480464 | resveratrol inhibits the reaction [[Streptozocin co-treated with Niacinamide] results in decreased expression of GCLC mRNA]; more ... | CTD | PMID:21439372 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 PMID:20418481 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [resveratrol results in increased expression of GCLC mRNA]; more ... | CTD | PMID:20418481 |
| trans-resveratrol | increases expression | ISO | RGD:619868 | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:15882976 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:11909699 |
| trans-resveratrol | increases expression | ISO | RGD:10652 | 6480464 | resveratrol results in increased expression of GCLC mRNA | CTD | PMID:21520053 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of GCLC mRNA]; more ... | CTD | PMID:11909699 |
| trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [Fenretinide co-treated with trichostatin A] results in increased expression of GCLC mRNA | CTD | PMID:21319187 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of GCLC mRNA | CTD | PMID:19140230 |
| tunicamycin | increases expression | ISO | RGD:10652 | 6480464 | Tunicamycin results in increased expression of GCLC mRNA | CTD | PMID:22959925 |
| tunicamycin | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 mRNA affects the reaction [Tunicamycin results in increased expression of GCLC mRNA] | CTD | PMID:22959925 |
| ursodeoxycholic acid | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA]; more ... | CTD | PMID:19073151 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:10652 | 6480464 | NFE2L2 affects the reaction [Ursodeoxycholic Acid results in increased expression of GCLC mRNA] | CTD | PMID:18687751 |
| ursodeoxycholic acid | increases expression | EXP | | 6480464 | Ursodeoxycholic Acid results in increased expression of GCLC mRNA | CTD | PMID:19073151 |
| ursodeoxycholic acid | increases expression | ISO | RGD:10652 | 6480464 | Ursodeoxycholic Acid results in increased expression of GCLC mRNA; more ... | CTD | PMID:18687751 |
| vanillin | increases expression | EXP | | 6480464 | vanillin results in increased expression of GCLC mRNA | CTD | PMID:17178418 |
| vincristine | multiple interactions | EXP | | 6480464 | [GCLC protein co-treated with GCLM protein] results in decreased susceptibility to Vincristine | CTD | PMID:10900222 |
| zinc dichloride | multiple interactions | EXP | | 6480464 | zinc chloride promotes the reaction [SLC39A2 protein results in increased expression of GCLC mRNA] | CTD | PMID:18385089 |